The Use of Proteomics in Diagnostics: Liver Fibrosis Biomarkers

The Use of Proteomics in Diagnostics: Liver Fibrosis Biomarkers

Pokaż inne wersje (1)

Proteomics can help to discover and quantify novel biomarkers and we show how this is achieved using liver fibrosis as an example.

Opis bibliograficzny
Główni autorzy:	Gangadharan, B, Kumar, A, Barnes, E, Klenerman, P, Dwek, R, Zitzmann, N
Format:	Conference item
Wydane:	Wiley 2016

Podobne zapisy

The Use of Proteomics in Diagnostics: Liver Fibrosis Biomarkers
od: Gangadharan, B, i wsp.
Wydane: (2016)

PTH-092 Discovery and quantitation of novel liver fibrosis biomarkers using proteomics
od: Gangadharan, B, i wsp.
Wydane: (2015)

Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients using proteomics
od: Gangadharan, B, i wsp.
Wydane: (2014)

New proteomics approaches for discovering biomarkers: Searching for liver fibrosis markers in hepatitis c patients
od: Gangadharan, B, i wsp.
Wydane: (2012)

New proteomic approaches for biomarker discovery: The search for novel liver fibrosis markers in hepatitis C patients
od: Gangadharan, B, i wsp.
Wydane: (2016)

New proteomic approaches for biomarker discovery: The search for novel liver fibrosis markers in hepatitis C patients
od: Gangadharan, B, i wsp.
Wydane: (2014)

Novel serum biomarker candidates for liver fibrosis in hepatitis C patients
od: Gangadharan, B, i wsp.
Wydane: (2007)

New approaches for biomarker discovery: the search for liver fibrosis markers in hepatitis C patients
od: Gangadharan, B, i wsp.
Wydane: (2011)

New approaches for biomarker discovery: the search for liver fibrosis markers in hepatitis C patients
od: Gangadharan, B, i wsp.
Wydane: (2011)

Discovery of new liver fibrosis markers in hepatitis C patients using proteomics
od: Gangadharan, B, i wsp.
Wydane: (2011)

Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study
od: Gangadharan, B, i wsp.
Wydane: (2012)

Clinical diagnosis of hepatic fibrosis using human serum APOL1 as biomarker
od: Gangadharan, B, i wsp.
Wydane: (2012)

Clinical diagnosis of hepatic fibrosis using a novel panel of human serum protein biomarkers
od: Gangadharan, B, i wsp.
Wydane: (2008)

Clinical diagnosis of hepatic fibrosis using a novel panel of low abundant human plasma protein biomarkers
od: Gangadharan, B, i wsp.
Wydane: (2010)

LC-MS based discovery of novel protein biomarkers and their quantitation in HCV fibrosis and NASH diseased human serum
od: Kumar, A, i wsp.
Wydane: (2014)

Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study.
od: Bevin Gangadharan, i wsp.
Wydane: (2012-01-01)

Proteomics in uveal melanoma research: opportunities and challenges in biomarker discovery.
od: Pardo, M, i wsp.
Wydane: (2007)

Towards the first antibody-free serum biomarker assay for NAFLD
od: Gangadharan, B, i wsp.
Wydane: (2017)

Discovery and quantitation of novel liver fibrosis biomarkers in hepatitis C patients
od: Gangadharan, B
Wydane: (2017)

Towards the first antibody-free serum biomarker assay for NAFLD
od: Gangadharan, B, i wsp.
Wydane: (2017)

Proteomic analysis of HepaRG cells: a novel cell line that supports hepatitis B virus infection.
od: Narayan, R, i wsp.
Wydane: (2009)

Applying proteomics technology to platelet research.
od: García, A, i wsp.
Wydane: (2005)

Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro.
od: Woodhouse, S, i wsp.
Wydane: (2010)

SOMAscan Proteomics Identifies Serum Biomarkers Associated With Liver Fibrosis in Patients With NASH
od: Yi Luo, i wsp.
Wydane: (2021-05-01)

Two dimensional gel electrophoresis using narrow pH 3-5.6 immobilised pH gradient strips identifies potential novel disease biomarkers in plasma or serum
od: Gangadharan, B, i wsp.
Wydane: (2011)

Mass spectrometry-based proteomic techniques to identify cerebrospinal fluid biomarkers for diagnosing suspected central nervous system infections. A systematic review.
od: Bharucha, T, i wsp.
Wydane: (2019)

Differential proteome analysis of CRP-activated platelets
od: Garcia, A, i wsp.
Wydane: (2005)

Absolute quantitation of disease protein biomarkers in a single LC-MS acquisition using apolipoprotein F as an example
od: Kumar, A, i wsp.
Wydane: (2017)

Diagnostics of Fibrosis in Alcoholic Liver Damage
od: E. N. Travenko, i wsp.
Wydane: (2019-09-01)

Non-invasive Diagnostics of Liver Fibrosis
od: Mihaylov R., i wsp.
Wydane: (2017-05-01)

Proteomic analysis of cells in the early stages of herpes simplex virus type-1 infection reveals widespread changes in the host cell proteome.
od: Antrobus, R, i wsp.
Wydane: (2009)

Use of iminosugar derivatives to inhibit ion channel activity
od: Zitzmann, N, i wsp.
Wydane: (2004)

Serum biomarkers for liver fibrosis assessment
od: Maroto-García Julia, i wsp.
Wydane: (2023-11-01)

Proteome analysis of human uveal melanoma cells by two-dimensional gel electrophoresis and mass spectrometry
od: Pardo, M, i wsp.
Wydane: (2005)

Proteome analysis of a human uveal melanoma primary cell culture by 2-DE and MS.
od: Pardo, M, i wsp.
Wydane: (2005)

Performance of diagnostic biomarkers in predicting liver fibrosis among hepatitis C virus-infected Egyptian children
od: Yasser E Nassef, i wsp.
Wydane: (2013-11-01)

Salivary biomarkers and proteomics: future diagnostic and clinical utilities
od: M. Castagnola, i wsp.
Wydane: (2017-04-01)

Diagnostic value of serum markers of fibrosis in chronic liver diseases
od: E V Vinnitskaia, i wsp.
Wydane: (2013-02-01)

Extensive analysis of the human platelet proteome by two-dimensional gel electrophoresis and mass spectrometry
od: García, A, i wsp.
Wydane: (2004)

Multiple reaction monitoring and multiple reaction monitoring cubed based assay for the quantitation of apolipoprotein F
od: Kumar, A, i wsp.
Wydane: (2016)